OncoTrack

Dubbed OncoTrack, the project is being funded for five years with around €27 million, and will involve whole-genome sequencing of the primary tumors of 60 colon cancer patients and matched normal genomes.

OncoTrack, a new international consortium, will seek to generate high-quality genomic and epigenetic data from clinically well-defined colon cancer tumors and their metastases as part of its colon cancer project.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.